Literature DB >> 31721082

The Veterans Aging Cohort Study Index is not associated with HIV-associated neurocognitive disorders in Uganda.

Violet Awori1, Gertrude Nakigozi2, Alice Kisakye2, James Batte2, Aggrey Anok2, Richard Mayanja2, Noeline Nakasujja3, Kevin R Robertson4, Ronald H Gray5, Maria J Wawer5, Ned Sacktor6, Deanna Saylor7,8.   

Abstract

The Veterans Aging Cohort Study (VACS) Index has been associated with HIV-associated neurocognitive disorder (HAND) in some populations but has not been studied in sub-Saharan Africa. We investigated whether the VACS Index is associated with HAND in a rural population in Rakai, Uganda. HIV-infected (HIV+) adults on antiretroviral therapy underwent a neurocognitive battery for determination of HAND stage using Frascati criteria. VACS component scores were recorded for all participants. Out of 156 study participants, HAND stages were 49% normal cognition, 15% asymptomatic neurocognitive impairment, 31% minor neurocognitive disorder, and 7% HIV-associated dementia. There was no significant association between VACS Index and any HAND stage. In this first study of the VACS Index in sub-Saharan Africa, we found no association between VACS Index score and HAND.

Entities:  

Keywords:  Global health; HIV; HIV-associated neurocognitive disorder; Uganda; Veterans aging cohort study index

Mesh:

Year:  2019        PMID: 31721082      PMCID: PMC8012007          DOI: 10.1007/s13365-019-00806-2

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  23 in total

1.  Prevalence of HIV-associated neurocognitive disorders in the Multicenter AIDS Cohort Study.

Authors:  Ned Sacktor; Richard L Skolasky; Eric Seaberg; Cynthia Munro; James T Becker; Eileen Martin; Ann Ragin; Andrew Levine; Eric Miller
Journal:  Neurology       Date:  2015-12-30       Impact factor: 9.910

2.  Anemia and Red Blood Cell Indices Predict HIV-Associated Neurocognitive Impairment in the Highly Active Antiretroviral Therapy Era.

Authors:  Asha R Kallianpur; Quan Wang; Peilin Jia; Todd Hulgan; Zhongming Zhao; Scott L Letendre; Ronald J Ellis; Robert K Heaton; Donald R Franklin; Jill Barnholtz-Sloan; Ann C Collier; Christina M Marra; David B Clifford; Benjamin B Gelman; Justin C McArthur; Susan Morgello; David M Simpson; J A McCutchan; Igor Grant
Journal:  J Infect Dis       Date:  2015-12-21       Impact factor: 5.226

3.  Baseline, Time-Updated, and Cumulative HIV Care Metrics for Predicting Acute Myocardial Infarction and All-Cause Mortality.

Authors:  Jorge L Salinas; Christopher Rentsch; Vincent C Marconi; Janet Tate; Matthew Budoff; Adeel A Butt; Matthew S Freiberg; Cynthia L Gibert; Matthew Bidwell Goetz; David Leaf; Maria C Rodriguez-Barradas; Amy C Justice; David Rimland
Journal:  Clin Infect Dis       Date:  2016-08-18       Impact factor: 9.079

4.  Higher Cystatin C Levels Are Associated With Neurocognitive Impairment in Older HIV+ Adults.

Authors:  Marissa E Sakoda; Pariya L Fazeli; Ronald J Ellis; Dilip V Jeste; Igor Grant; Scott L Letendre; David J Moore
Journal:  J Acquir Immune Defic Syndr       Date:  2017-03-01       Impact factor: 3.731

5.  A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.

Authors:  S M Hammer; K E Squires; M D Hughes; J M Grimes; L M Demeter; J S Currier; J J Eron; J E Feinberg; H H Balfour; L R Deyton; J A Chodakewitz; M A Fischl
Journal:  N Engl J Med       Date:  1997-09-11       Impact factor: 91.245

6.  FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest.

Authors:  Anaïs Vallet-Pichard; Vincent Mallet; Bertrand Nalpas; Virginie Verkarre; Antoine Nalpas; Valérie Dhalluin-Venier; Hélène Fontaine; Stanislas Pol
Journal:  Hepatology       Date:  2007-07       Impact factor: 17.425

7.  Does an index composed of clinical data reflect effects of inflammation, coagulation, and monocyte activation on mortality among those aging with HIV?

Authors:  Amy C Justice; Matthew S Freiberg; Russ Tracy; Lew Kuller; Janet P Tate; Matthew Bidwell Goetz; David A Fiellin; Gary J Vanasse; Adeel A Butt; Maria C Rodriguez-Barradas; Cynthia Gibert; Kris Ann Oursler; Steven G Deeks; Kendall Bryant
Journal:  Clin Infect Dis       Date:  2012-02-15       Impact factor: 9.079

8.  A composite of multisystem injury and neurocognitive impairment in HIV infection: association with everyday functioning.

Authors:  María J Marquine; Ilse Flores; Rujvi Kamat; Neco Johnson; Anya Umlauf; Scott Letendre; Dilip Jeste; Igor Grant; David Moore; Robert K Heaton
Journal:  J Neurovirol       Date:  2018-05-17       Impact factor: 2.643

9.  The impact of ethnicity/race on the association between the Veterans Aging Cohort Study (VACS) Index and neurocognitive function among HIV-infected persons.

Authors:  M J Marquine; M Sakamoto; C Dufour; A Rooney; P Fazeli; A Umlauf; B Gouaux; D Franklin; R Ellis; S Letendre; M Cherner; R K Heaton; I Grant; D J Moore
Journal:  J Neurovirol       Date:  2015-12-17       Impact factor: 2.643

10.  Personalized Risk Index for Neurocognitive Decline Among People With Well-Controlled HIV Infection.

Authors:  Tracy Yuen; Marie-Josée Brouillette; Lesley K Fellows; Ronald J Ellis; Scott Letendre; Robert Heaton; Nancy Mayo
Journal:  J Acquir Immune Defic Syndr       Date:  2017-09-01       Impact factor: 3.771

View more
  2 in total

1.  Screening Accuracy of Mini Addenbrooke's Cognitive Examination Test for HIV-Associated Neurocognitive Disorders in People Ageing with HIV.

Authors:  Mattia Trunfio; Davide De Francesco; Daniela Vai; Caterina Medina; Maurizio Milesi; Simone Domini; Chiara Alcantarini; Daniele Imperiale; Stefano Bonora; Giovanni Di Perri; Andrea Calcagno
Journal:  AIDS Behav       Date:  2022-01-04

2.  Association between Veterans Aging Cohort Study (VACS) index and neurocognitive function among people living with HIV-a cross sectional study in coastal South India.

Authors:  Archana Ganapathy; Basavaprabhu Achappa; Vaman Kulkarni; Deepak Madi; Ramesh Holla; Unnikrishnan Bhaskaran; Priya Rathi; Soundarya Mahalingam; Nikhil Victor Dsouza
Journal:  AIDS Res Ther       Date:  2021-08-04       Impact factor: 2.250

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.